Skip to main content

Dempze Nancy E

SEC CIK
0001592614
Latest filing
Aug 12, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Dempze Nancy E, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
42,366
Value
$3.84M
% of portfolio
1.8%
Quarters held
22
Since Q1 2021
Holdings of ABT by Dempze Nancy E, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,366$3.84M1.8%−1,984−4.5%ReducedHolders
Q1 202644,350$4.55M2.5%+1,115+2.6%AddedHolders
Q4 202543,235$5.42M2.8%+641+1.5%AddedHolders
Q3 202542,594$5.71M3.1%+286+0.7%AddedHolders
Q2 202542,308$5.75M3.3%−354−0.8%ReducedHolders
Q1 202542,662$5.66M3.4%+985+2.4%AddedHolders
Q4 202441,677$4.71M2.7%+1,865+4.7%AddedHolders
Q3 202439,812$4.54M2.5%+2,365+6.3%AddedHolders
Q2 202437,447$3.89M2.7%+890+2.4%AddedHolders
Q1 202436,557$4.16M3.2%+832+2.3%AddedHolders
Q4 202335,725$3.93M3.3%+1,405+4.1%AddedHolders
Q3 202334,320$3.32M3.0%+697+2.1%AddedHolders
Q2 202333,623$3.67M3.1%+1,082+3.3%AddedHolders
Q1 202332,541$3.30M3.0%+607+1.9%AddedHolders
Q4 202231,934$3.51M3.4%+1,264+4.1%AddedHolders
Q3 202230,670$2.97M3.2%+20.0%AddedHolders
Q2 202230,668$3.33M3.3%−4,671−13.2%ReducedHolders
Q1 202235,339$4.18M3.1%−35−0.1%ReducedHolders
Q4 202135,374$4.98M3.4%+897+2.6%AddedHolders
Q3 202134,477$4.07M3.2%−80−0.2%ReducedHolders
Q2 202134,557$4.01M3.4%−3,785−9.9%ReducedHolders
Q1 202138,342$4.60M4.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.